These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 10542818)
1. When drugs are in short supply. Zurlinden J Nurs Spectr (Wash D C); 1999 Feb; 9(4):15-6. PubMed ID: 10542818 [No Abstract] [Full Text] [Related]
2. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
3. Orphan drug development in the United States. Groft SC CPJ; 1985 May; 118(5):219-22. PubMed ID: 10271306 [TBL] [Abstract][Full Text] [Related]
4. The Pharmaceutical Manufacturers Association Commission on Drugs for Rare Diseases. Goldstein GS Prog Clin Biol Res; 1985; 197():35-9. PubMed ID: 4070297 [No Abstract] [Full Text] [Related]
5. Pediatric testing of prescription drugs: the Food and Drug Administration's carrot and stick for the pharmaceutical industry. Karst KR Am Univ Law Rev; 2000; 49():739-72. PubMed ID: 11067732 [No Abstract] [Full Text] [Related]
6. Seizures of Canadian drugs rise as Congress, Customs spar. Carreyrou J Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501 [No Abstract] [Full Text] [Related]
7. Studies involving orphan products for treating/diagnosing women's diseases. Haffner ME Food Drug Law J; 1993; 48(2):205-11. PubMed ID: 11653144 [No Abstract] [Full Text] [Related]
8. Problems associated with developing orphan drugs into available therapy. Van Woert MH Prog Clin Biol Res; 1985; 197():171-3. PubMed ID: 4070291 [No Abstract] [Full Text] [Related]
9. Generic Pharmaceutical Industry Association Orphan Drug Institute. Haddad W Prog Clin Biol Res; 1985; 197():41-5. PubMed ID: 4070298 [No Abstract] [Full Text] [Related]
10. The meaning of the "me-too" drug decision. Archambault GF Hosp Formul; 1975 Oct; 10(10):510. PubMed ID: 10316671 [No Abstract] [Full Text] [Related]
11. The future of orphan drug development. Woodcock J Clin Pharmacol Ther; 2012 Aug; 92(2):146-8. PubMed ID: 22814657 [No Abstract] [Full Text] [Related]
12. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures. Dunbar MM Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380 [No Abstract] [Full Text] [Related]
14. [Orphan drugs]. Galeffi C Ann Ist Super Sanita; 1991; 27(2):341-3. PubMed ID: 1661568 [TBL] [Abstract][Full Text] [Related]
15. Should off-label drug use be off-the-table? Rivkees SA J Pediatr Endocrinol Metab; 2007 Feb; 20(2):171-2. PubMed ID: 17396432 [No Abstract] [Full Text] [Related]
16. Orphan Drug Act on congressional agenda. von Oehsen WH Physician Exec; 1989; 15(3):34-5. PubMed ID: 10313123 [TBL] [Abstract][Full Text] [Related]
19. Orphan drug development for the treatment of rare chronic diseases. Moore ES Tex Hosp; 1988 Jul; 44(2):20-1. PubMed ID: 10288218 [No Abstract] [Full Text] [Related]
20. Drug shortage crisis affects patients and nurses. Carter D Am J Nurs; 2011 Nov; 111(11):14. PubMed ID: 22030911 [No Abstract] [Full Text] [Related] [Next] [New Search]